VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MHNCMaiden Holdings North America, Ltd.
$12.25$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMHNCQuarterly Financials

Maiden Holdings North America, Ltd. (MHNC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Maiden Holdings North America, Ltd. (MHNC) quarterly income statement — complete revenue, gross profit & net income history

MHNC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'25Q4'24Q3'24Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q4'20Q1'12
Revenue14.05M-7.43M14.48M40.45M17.68M20.69M10.05M11.35M21.71M21.98M0463.05B
Revenue Growth %---256.4%-18.54%-5.86%------
Medical Costs & Claims000000000001.09B
Medical Cost Ratio %0%0%0%0%0%0%0%0%0%0%-0.24%
Gross Profit14.05M-63.87M14.48M40.45M17.68M20.69M10.05M11.35M21.71M21.98M0461.96B
Gross Margin %100%859.36%100%100%100%100%100%100%100%100%-99.76%
Gross Profit Growth %---256.4%-18.54%-5.86%------
Operating Expenses10.77M9.39M10.01M92.96M25.56M17.3M10.89M20.46M6.65M8.91M1.79M13.83B
OpEx / Revenue %76.68%-126.41%69.17%229.83%144.55%83.62%108.33%180.32%30.63%40.52%-2.99%
Depreciation & Amortization0-43.28K054.88K27.08K86.06K60.46K16.3M7.8M6.84M1.85M0
Combined Ratio %76.68%-126.41%69.17%229.83%144.55%83.62%108.33%180.32%30.63%40.52%-3.22%
Operating Income03.6M4.46M63.76M11.56M31.3M7.68M24.07M-2.48M5.08M1.79M448.13B
Operating Margin %0%-48.39%30.83%157.63%65.38%151.27%76.44%212.05%-11.45%23.11%-96.78%
Operating Income Growth %---164.94%565.23%516.1%-1241.42%----
EBITDA03.55M4.46M63.81M11.59M31.38M7.74M40.36M5.31M11.92M3.64M448.13B
EBITDA Margin %0%-47.8%30.83%157.77%65.53%151.69%77.04%355.63%24.47%54.24%-96.78%
Interest Expense4.82M4.82M4.82M14.5M4.83M4.83M4.83M19.33M4.83M4.83M07.68B
Non-Operating Income0-34.09M34.09M00000000419.2B
Pretax Income-8.63M-157.41M-34.44M49.26M6.73M26.46M2.85M24.07M-2.48M5.08M021.26B
Pretax Margin %-61.45%2118.03%-237.92%121.79%38.05%127.91%28.35%212.05%-11.45%23.11%-4.59%
Income Tax12K577K25K466K91K713K1.25M170K-155K-4.83M0879M
Effective Tax Rate %-0.14%-0.37%-0.07%0.95%1.35%2.69%44.05%0.71%6.24%-95.12%-4.14%
Net Income-8.64M-157.99M-34.47M48.8M6.64M25.75M1.59M23.89M-2.33M8.11M020.38B
Net Margin %-61.53%2125.79%-238.09%120.64%37.53%124.47%15.86%210.55%-10.73%36.91%-4.4%
Net Income Growth %---104.21%384.85%217.46%------
EPS (Diluted)-0.090.43-0.350.560.080.300.020.28-0.030.090.000.28
EPS Growth %---100%382.9%220.17%------
EPS (Basic)-0.090.43-0.350.560.080.300.020.28-0.030.090.000.28
Diluted Shares Outstanding99.12M99.9M99.72M87.16M87.16M87.09M86.55M86.55M86.55M86.24M85.26M0